|
| Status |
Public on Apr 25, 2022 |
| Title |
RNA polymerase II (RNAPII) ChIP-seq analysis evaluating effects of Cdk7 inhibitor THZ1 on responses of neonatal rat ventricular myocytes (NRVM) to adrenergic receptor agonist phenylephrine (PE) |
| Organism |
Rattus norvegicus |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
RNA polymerase II (RNAPII) ChIP-seq analysis evaluating effects of Cdk7 inhibitor THZ1 on responses of NRVM to adrenergic receptor agonist PE
|
| |
|
| Overall design |
Profiles of NRVM RNAPII occupancies from three groups: 1. Vehicle; 2. PE (100 μM); 3. PE (100 μM)+THZ1(10 nM);
|
| |
|
| Contributor(s) |
Duan Q, Day D |
| Citation(s) |
35896549 |
| |
| Submission date |
May 27, 2020 |
| Last update date |
Jul 29, 2022 |
| Contact name |
Saptarsi Haldar |
| E-mail(s) |
shalda01@amgen.com
|
| Organization name |
Amgen
|
| Street address |
1120 Veterans Blvd
|
| City |
South San Francisco |
| State/province |
CA |
| ZIP/Postal code |
94080 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL18694 |
Illumina HiSeq 2500 (Rattus norvegicus) |
|
| Samples (6)
|
|
| Relations |
| BioProject |
PRJNA635293 |
| SRA |
SRP264911 |
Less...
More...